Research
Hormonal
Women begin to lose lean mass during menopause, leading to an increase in fat mass.
Practitioners should monitor body composition changes in menopausal women.
StrongSupportsmedium confidence
women begin to lose lean mass up to 0.5% and, therefore, an increase in the percentage of fat mass.
Why this rating
The claim is based on established knowledge in the field.
Source
Effectiveness of Low Doses of Semaglutide on Weight Loss and Body Composition Among Women in Their Menopause
Joana Nicolau et al. · Metabolic Syndrome and Related Disorders · 2025
DOI 10.1089/met.2024.0124
otherCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →